Glucocorticoid Receptor Blockers Pretreatment Did Not Improve Infarct Volume in Type-2 Diabetic Mouse Model of Stroke
Open Access
- 21 October 2022
- journal article
- research article
- Published by MDPI AG in Diabetology
- Vol. 3 (4) , 539-548
Abstract
Impaired glucocorticoid signaling in diabetes mellitus and its relation to suppressed immune function and hyperglycemia during acute stroke has been shown to be detrimental. Therefore, the aim of this study was to examine the effect of glucocorticoid receptor (GCR) blockers in a type-2 diabetic mouse model following hypoxia–ischemia (HI). We induced stroke in diabetic db/db and non-diabetic db/+ mice by unilateral common carotid artery ligation followed by 20 min of HI. Mice were pretreated with RU-486, GCRII blocker (40 mg/kg), intraperitoneally, the day before, during stroke and post-HI. Blood and brain samples were collected at 24 h post-HI to measure blood glucose, corticosterone and infarct size. Similarly, another set of mice was pretreated with RU-486 + spironolactone, GCR1 blocker (25 mg/kg) subcutaneously for a week before inducing stroke and during recovery. Samples were collected at 48 h post-HI for various analyses. RU-486 treatment did not lower the blood glucose significantly, but RU-486 + spironolactone decreased the blood glucose in db/db mice post-HI. However, none of the treatment groups decreased the ischemia-induced serum corticosterone level or infarct size. This study suggests that even though GCR blockers improve hyperglycemia, they did not improve the infarct volume.Keywords
Funding Information
- National Institute of Health (DK75130)
This publication has 30 references indexed in Scilit:
- Increased cerebral matrix metalloprotease‐9 activity is associated with compromised recovery in the diabetic db/db mouse following a strokeJournal of Neurochemistry, 2011
- REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockadeBiochemical and Biophysical Research Communications, 2011
- The PPAR-γ Agonist, Darglitazone, Restores Acute Inflammatory Responses to Cerebral Hypoxia–Ischemia in the Diabetic ob/ob MouseJournal of Cerebral Blood Flow & Metabolism, 2009
- Impaired Wound Healing after Cerebral Hypoxia—Ischemia in the Diabetic MouseJournal of Cerebral Blood Flow & Metabolism, 2007
- Why Does Acute Hyperglycemia Worsen the Outcome of Transient Focal Cerebral Ischemia?Stroke, 2006
- Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after strokeJournal of Internal Medicine, 2004
- Polyamines play a critical role in the control of the innate immune response in the mouse central nervous systemJournal of Cell Biology, 2003
- Metyrapone, an Inhibitor of Glucocorticoid Production, Reduces Brain Injury Induced by Focal and Global Ischemia and SeizuresJournal of Cerebral Blood Flow & Metabolism, 1996
- Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of ConfusionStress, 1996
- Adrenalectomy and Steroid Treatment in Obese (ob/ob) and Diabetic (db/db) MiceHormone and Metabolic Research, 1987